Surgical Technique and Experimental Surgery Department, University of São Paulo School of Medicine, AV. Dr. Arnaldo, 455, Room 2145, Sao Paulo, SP, 01246-903, Brazil.
German Hospital Oswaldo Cruz - Specialized Center for Urology, São Paulo, SP, Brazil.
BMC Urol. 2024 Nov 1;24(1):239. doi: 10.1186/s12894-024-01632-3.
The use of pneumoperitoneum is an essential step for performing laparoscopic and robotic surgery. Pneumoperitoneum insufflation can cause complications such as pneumothorax, subcutaneous emphysema, and pneumomediastinum. The purpose of this meta-analysis is to compare the safety of using the conventional insufflation system versus a Valveless insufflation system as devices for manufacturing pneumoperitoneum in robotic-assisted nephrectomy.
A comprehensive literature search was conducted on PUBMED, EMBASE, SCOPUS, and Cochrane, from inception until January 2024. Randomized and nonrandomized prospective studies were included in the meta-analysis, performed by the R+ Rstudio.
Three publications encompassing 478 patients were included. We observed no difference in SCE (OR 0.60, CI 95% 0.27;1.34, p = 0.134, I = 0), PNM (OR 0.82, CI 95% 0.24;2.78, p = 0.558, I = 0), When comparing groups conventional insufflation system (CIS) versus AirSealTM insufflation system (AIS) with pneumoperitoneum pressure of 15 mmHg or 12 mmHg.
The presented data showed no difference between the AIS when compared with CIS in Pneumoperitoneum insufflation-related complications.
气腹的使用是进行腹腔镜和机器人手术的重要步骤。气腹充气可能会导致气胸、皮下气肿和纵隔气肿等并发症。本荟萃分析的目的是比较使用常规充气系统与无阀充气系统作为机器人辅助肾切除术中制造气腹的设备的安全性。
对 PUBMED、EMBASE、SCOPUS 和 Cochrane 进行了全面的文献检索,检索时间从创建到 2024 年 1 月。荟萃分析纳入了随机和非随机前瞻性研究,由 R+Rstudio 进行。
共纳入了 3 项包含 478 例患者的研究。我们观察到 SCE(OR 0.60,95%CI 0.27;1.34,p=0.134,I=0)和 PNM(OR 0.82,95%CI 0.24;2.78,p=0.558,I=0)之间没有差异,比较了充气压力为 15mmHg 或 12mmHg 时的常规充气系统(CIS)与 AirSealTM 充气系统(AIS)。
与 CIS 相比,AIS 在气腹充气相关并发症方面没有差异。